Circulating matrix metalloproteinase-9 is transiently elevated after colorectal surgery

Int J Colorectal Dis. 2004 Sep;19(5):446-50. doi: 10.1007/s00384-004-0578-4. Epub 2004 Feb 17.

Abstract

Background and aims: Plasma levels of matrix metalloproteinases (MMPs) may yield important information in patients suffering from colorectal cancer but the effect of surgery, a common treatment modality in these patients, on circulating MMP levels is currently unknown. The aim of this study was to assess whether plasma MMP-2 and MMP-9 levels are affected by operative procedures.

Materials and methods: In total 128 patients undergoing elective surgery for colorectal cancer (n = 66), liver metastases from colorectal origin (n = 50) and arthrosis of the hip (n = 12) were included in the study. Gelatinase activity was measured, using quantitative gelatin zymography, in plasma obtained before operation and 1 week, 1 month and 3 months postoperatively.

Results: One week after operation a significant increase in proMMP-9 activity was measured after colorectal surgery (260%, p = 0.0038), liver surgery (285%, p < 0.0001) and hip surgery (217%, p = 0.012) as compared with preoperative levels. After 1 month proMMP-9 activity had returned to preoperative levels. No effect on proMMP-2 activity was measured.

Conclusion: Operative procedures have a profound but transient effect on plasma MMP-9 activity. If used to assess disease status, postoperative plasma MMP levels should be interpreted with caution.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Arthroplasty, Replacement, Hip
  • Biomarkers, Tumor / analysis*
  • Colorectal Neoplasms / surgery*
  • Female
  • Humans
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / surgery*
  • Male
  • Matrix Metalloproteinase 9 / blood*
  • Middle Aged
  • Neoplasm Staging / methods
  • Reproducibility of Results

Substances

  • Biomarkers, Tumor
  • Matrix Metalloproteinase 9